Skip to main content
. 2015 May 19;26(11):2852–2859. doi: 10.1681/ASN.2014040406

Table 1.

C4d staining in immune complex-mediated GN

Patient Pathology Diagnosis C4d C3 C1q Ig
1 Chronic MPGN, monoclonal gammopathy associated (κ light chains) 1–2 3 0 κ 3+negative IgG, IgM, IgA, λ
2 MPGN, hepatitis C associated 2 3 0 IgM 3+, IgG 2+, κ 3+, λ 2+
3 MPGN, monoclonal gammopathy associated (IgM κ) 3 3 0 IgM 3+, κ 3+negative IgA, IgG
4 IgA nephropathy 0 1 0 IgA 3+, IgM 1+, κ 2+, λ 2+
5 Lupus nephritis 3 3 1 IgA 2+, IgG 3+, IgM 2+, κ 3+, λ 3+
6 Membranous nephropathy 3 3 0 IgG 3+, κ 3+, λ 3+
7 Membranous nephropathy 3 3 0 IgG 3+, IgM 2+, κ 3+, λ 3+
8 IgA nephropathy 0 2 0 IgA 3+, κ 2+, λ 3+
9 Lupus nephritis 3 3 2 IgA 3+, IgG 3+, IgM 2+, κ 3+, λ 3+
10 MPGN, autoimmune 3 3 2 IgG 3+, IgA 3+, IgM 3+, κ 3+, λ 3+
11 Fibrillary GN 3 3 0 IgG 3+, κ 2+, λ 3+
12 Membranous nephropathy 2 3 0 IgG 3+, κ 3+, λ 3+
13 MPGN (C3GN versus immune complex-mediated) 3 3 0 IgG 1+, κ 1+
14 Lupus membranous, early 2 3 0 IgG 3+, κ 2–3+, λ 2–3+
15 Membranous nephropathy 2 3 0 IgG 3+, κ 3+, λ 3+
16 Lupus nephritis 3 3 3 IgA 3+, IgG 3+, IgM 1+, κ 3+, λ 3+
17 Lupus nephritis 3 2 3 IgA 3+, IgG 3+, IgM 2+, κ 3+, λ 3+
18 Fibrillary GN 3 3 0 IgG 3+, κ 2+, λ 3+